greeksoup/ stock research

Humana (HUM) FY2022 results: revenue $92.9 billion, up 11.8% on the year

Humana Inc. (HUM) reported revenue of $92.9 billion for fiscal 2022, the year ended 31 December 2022, up 11.8% on the year before. Net income was $2.8 billion, down 4.3%, and diluted earnings per share $22.08. The figures are the company's own, from the 10-K it filed with the SEC on 16 February 2023.

Revenue
$92.9 billion
+11.8% on the year
FY2015FY2022
Operating margin
4.1%
3.8% a year earlier
FY2015FY2022
Net income
$2.8 billion
-4.3% on the year
FY2015FY2022
Diluted EPS
$22.08
-2.6% on the year
FY2015FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue92,87083,06477,155+11.8%
Selling, general and administrative12,67110,12110,052+25.2%
Operating income3,8003,1484,986+20.7%
Operating margin4.1%3.8%6.5%
Interest expense401326283+23.0%
Pre-tax income3,5643,4194,674+4.2%
Income tax7624851,307+57.1%
Effective tax rate21.4%14.2%28.0%
Net income2,8062,9333,367-4.3%
Net margin3.0%3.5%4.4%
Diluted EPS$22.08$22.67$25.31-2.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow4,5872,2625,639+102.8%
Capital expenditure1,1371,342964-15.3%
Free cash flow3,4509204,675+275.0%
Free cash flow margin3.7%1.1%6.1%
Cash from investing-1,006-6,556-3,065
Cash from financing-1,9143,015-1,955
Depreciation and amortisation709596616+19.0%
Share-based compensation216180181+20.0%
Buybacks2,09679.01,820+2,553.2%
Dividends paid98.090.0323+8.9%
Dividend per share$3.06$2.73$2.43+12.1%
Diluted shares, weighted127m129m133m-1.8%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity15,31116,08013,728-4.8%
Non-controlling interest59.023.00.0+156.5%
Debt11,12612,4946,660-10.9%
Operating lease liabilities456546355-16.5%
Other liabilities16,10315,21514,226+5.8%
Total liabilities and equity43,05544,35834,969-2.9%
Fixed assets3,2213,0732,371+4.8%
Goodwill9,14211,0924,447-17.6%
Intangible assets1,7652,639329-33.1%
Investments14,26113,97213,766+2.1%
Cash and equivalents5,0613,3944,673+49.1%
Receivables1,6741,8141,138-7.7%
Other assets7,9318,3748,245-5.3%
Total assets43,05544,35834,969-2.9%

10-K for the year ended 31 December 2022, filed 16 February 2023: the filing.